advertisement
Cell reports. Medicine 35
Showing records 1 to 25 | Display all abstracts in Cell reports. Medicine116776 Novel ancestry-specific primary open-angle glaucoma loci and shared biology with vascular mechanisms and cell proliferation
Lo Faro V
Cell reports. Medicine 2024; 5: 101430
117813 CRISPR-Cas9-mediated deletion of carbonic anhydrase 2 in the ciliary body to treat glaucoma
Jiang J
Cell reports. Medicine 2024; 5: 101524
118608 CRISPR editing of anti-anemia drug target rescues independent preclinical models of retinitis pigmentosa
Nolan ND
Cell reports. Medicine 2024; 5: 101459
117813 CRISPR-Cas9-mediated deletion of carbonic anhydrase 2 in the ciliary body to treat glaucoma
Kong K
Cell reports. Medicine 2024; 5: 101524
118608 CRISPR editing of anti-anemia drug target rescues independent preclinical models of retinitis pigmentosa
Cui X
Cell reports. Medicine 2024; 5: 101459
116776 Novel ancestry-specific primary open-angle glaucoma loci and shared biology with vascular mechanisms and cell proliferation
Bhattacharya A; Zhou W
Cell reports. Medicine 2024; 5: 101430
117813 CRISPR-Cas9-mediated deletion of carbonic anhydrase 2 in the ciliary body to treat glaucoma
Fang X
Cell reports. Medicine 2024; 5: 101524
118608 CRISPR editing of anti-anemia drug target rescues independent preclinical models of retinitis pigmentosa
Robbings BM; Demirkol A
Cell reports. Medicine 2024; 5: 101459
117813 CRISPR-Cas9-mediated deletion of carbonic anhydrase 2 in the ciliary body to treat glaucoma
Wang D
Cell reports. Medicine 2024; 5: 101524
116776 Novel ancestry-specific primary open-angle glaucoma loci and shared biology with vascular mechanisms and cell proliferation
Zhou D
Cell reports. Medicine 2024; 5: 101430
118608 CRISPR editing of anti-anemia drug target rescues independent preclinical models of retinitis pigmentosa
Pandey K
Cell reports. Medicine 2024; 5: 101459
116776 Novel ancestry-specific primary open-angle glaucoma loci and shared biology with vascular mechanisms and cell proliferation
Wang Y
Cell reports. Medicine 2024; 5: 101430
117813 CRISPR-Cas9-mediated deletion of carbonic anhydrase 2 in the ciliary body to treat glaucoma
Zhang Y
Cell reports. Medicine 2024; 5: 101524
118608 CRISPR editing of anti-anemia drug target rescues independent preclinical models of retinitis pigmentosa
Wu WH
Cell reports. Medicine 2024; 5: 101459
116776 Novel ancestry-specific primary open-angle glaucoma loci and shared biology with vascular mechanisms and cell proliferation
Läll K
Cell reports. Medicine 2024; 5: 101430
117813 CRISPR-Cas9-mediated deletion of carbonic anhydrase 2 in the ciliary body to treat glaucoma
Wang P; Yang Z
Cell reports. Medicine 2024; 5: 101524
118608 CRISPR editing of anti-anemia drug target rescues independent preclinical models of retinitis pigmentosa
Hu HF
Cell reports. Medicine 2024; 5: 101459
116776 Novel ancestry-specific primary open-angle glaucoma loci and shared biology with vascular mechanisms and cell proliferation
Kanai M; Lopera-Maya E
Cell reports. Medicine 2024; 5: 101430
118608 CRISPR editing of anti-anemia drug target rescues independent preclinical models of retinitis pigmentosa
Jenny LA
Cell reports. Medicine 2024; 5: 101459
116776 Novel ancestry-specific primary open-angle glaucoma loci and shared biology with vascular mechanisms and cell proliferation
Straub P
Cell reports. Medicine 2024; 5: 101430
117813 CRISPR-Cas9-mediated deletion of carbonic anhydrase 2 in the ciliary body to treat glaucoma
Liu X
Cell reports. Medicine 2024; 5: 101524
118608 CRISPR editing of anti-anemia drug target rescues independent preclinical models of retinitis pigmentosa
Lin CS; Hass DT
Cell reports. Medicine 2024; 5: 101459
116776 Novel ancestry-specific primary open-angle glaucoma loci and shared biology with vascular mechanisms and cell proliferation
Pawar P
Cell reports. Medicine 2024; 5: 101430
117813 CRISPR-Cas9-mediated deletion of carbonic anhydrase 2 in the ciliary body to treat glaucoma
Aung T
Cell reports. Medicine 2024; 5: 101524
118608 CRISPR editing of anti-anemia drug target rescues independent preclinical models of retinitis pigmentosa
Hass DT
Cell reports. Medicine 2024; 5: 101459
